Other OTC - Delayed Quote USD

Plandaí Biotechnology, Inc. (PLPL)

0.0004 +0.0002 (+100.00%)
At close: 3:51 PM EDT
Loading Chart for PLPL
DELL
  • Previous Close 0.0002
  • Open 0.0002
  • Bid --
  • Ask --
  • Day's Range 0.0002 - 0.0005
  • 52 Week Range 0.0001 - 0.0011
  • Volume 550,982,967
  • Avg. Volume 55,897,924
  • Market Cap (intraday) 7.111M
  • Beta (5Y Monthly) -1.74
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Plandaí Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. It is developing Phytofare Catechin Complex, a botanical extract derived from green tea harvested in the Senteeko Tea Estate in Mpumalanga, South Africa; and Phytofare citrus complex, a citrus extract, as well as extracts from tomato fruit, Artemisia, and cannabis. The company also produces and sells timber and agricultural products from its farm and tea estate holdings in South Africa. Plandaí Biotechnology, Inc. is based in London, the United Kingdom.

www.plandaibiotech.com

180

Full Time Employees

June 30

Fiscal Year Ends

Recent News: PLPL

Performance Overview: PLPL

Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

PLPL
100.00%
S&P 500
11.29%

1-Year Return

PLPL
11.11%
S&P 500
28.71%

3-Year Return

PLPL
50.00%
S&P 500
27.18%

5-Year Return

PLPL
63.64%
S&P 500
87.28%

Compare To: PLPL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PLPL

Valuation Measures

Annual
As of 5/14/2024
  • Market Cap

    1.78M

  • Enterprise Value

    1.83M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -26.23%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    338.48k

  • Net Income Avi to Common (ttm)

    -4.32M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    22.09k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -330.7k

Research Analysis: PLPL

Company Insights: PLPL

Research Reports: PLPL

People Also Watch